These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20626181)

  • 1. Thymidylate synthase mRNA expression does not predict resistance to floxuridine in a choriocarcinoma cell line.
    Han B; Xiang Y; Sha GH; Zhang H; Liu X
    J Reprod Med; 2010; 55(5-6):247-52. PubMed ID: 20626181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Establishment of floxuridine-resistant JeG-3 subline and the role of thymidylate synthetase mRNA expression in chem-resistant-prediction.].
    Han B; Xiang Y; Sha GH; Zhang H; Liu X
    Zhonghua Fu Chan Ke Za Zhi; 2009 Nov; 44(11):851-5. PubMed ID: 20079039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents.
    Yawata A; Kim SR; Miyajima A; Kubo T; Ishida S; Saito Y; Nakajima Y; Katori N; Matsumoto Y; Fukuoka M; Ohno Y; Ozawa S; Sawada J
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):465-72. PubMed ID: 15918040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of C1QBP gene and its correlation with drug resistance in human resistance choriocarcinoma cell line].
    Shen X; Han B; Shen Y; Yang J; Ren T; Sha G; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):616-20. PubMed ID: 25354864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydrofolate reductase transcript level is not suitable for methotrexate-resistance prediction in choriocarcinoma cell line.
    Han B; Xiang Y; Wang Y; Wang Z; Zhang H; Huang S
    Int J Gynecol Cancer; 2010 Oct; 20(7):1259-63. PubMed ID: 21495249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment of the drug resistant cell line of choriocarcinoma and the reversal of drug resistance by transfection of human interleukin 2 gene].
    Cui Z; Xiang Y; Yang X
    Zhonghua Fu Chan Ke Za Zhi; 2001 Sep; 36(9):549-53. PubMed ID: 11769671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense-induced down-regulation of thymidylate synthase and enhanced cytotoxicity of 5-FUdR in 5-FUdR-resistant HeLa cells.
    Ferguson PJ; DeMoor JM; Vincent MD; Koropatnick J
    Br J Pharmacol; 2001 Dec; 134(7):1437-46. PubMed ID: 11724749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of endoplasmic reticulum protein folding molecular chaperones in floxuridine-resistance choriocarcinoma JeG-3/FUDRA cell line].
    Han B; Xiang Y; Feng FZ; Wan XR; Qian HL; Zhang XY; Meng XT; Lin C
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jan; 48(1):41-5. PubMed ID: 23531250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLIC1 Induces Drug Resistance in Human Choriocarcinoma Through Positive Regulation of MRP1.
    Wu J; Wang D
    Oncol Res; 2017 Jul; 25(6):863-871. PubMed ID: 27983917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of colorectal cancer cells to 5-FUdR and 5-FU caused by Mycoplasma infection.
    Jetté L; Bissoon-Haqqani S; Le François B; Maroun JA; Birnboim HC
    Anticancer Res; 2008; 28(4B):2175-80. PubMed ID: 18751392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic exposure of colorectal cancer cells in culture to fluoropyrimidine analogs induces thymidylate synthase and suppresses p53. A molecular explanation for the mechanism of 5-FU resistance.
    Subbarayan PR; Sarkar M; Nelson G; Benitez E; Singhal S; Ardalan B
    Anticancer Res; 2010 Apr; 30(4):1149-56. PubMed ID: 20530421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
    Chu E; Drake JC; Koeller DM; Zinn S; Jamis-Dow CA; Yeh GC; Allegra CJ
    Mol Pharmacol; 1991 Feb; 39(2):136-43. PubMed ID: 1704999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
    Grem JL; Danenberg KD; Behan K; Parr A; Young L; Danenberg PV; Nguyen D; Drake J; Monks A; Allegra CJ
    Clin Cancer Res; 2001 Apr; 7(4):999-1009. PubMed ID: 11309351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense down-regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of 5-FUdR, 5-FU and Tomudex in HeLa cells.
    Ferguson PJ; Collins O; Dean NM; DeMoor J; Li CS; Vincent MD; Koropatnick J
    Br J Pharmacol; 1999 Aug; 127(8):1777-86. PubMed ID: 10482907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymidylate synthetase mRNA levels are increased in liver metastases of colorectal cancer patients resistant to fluoropyrimidine-based chemotherapy.
    Libra M; Navolanic PM; Talamini R; Cecchin E; Sartor F; Tumolo S; Masier S; Travali S; Boiocchi M; Toffoli G
    BMC Cancer; 2004 Mar; 4():11. PubMed ID: 15040806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic copy number changes affecting the thymidylate synthase (TYMS) gene in cancer: a model for patient classification to aid fluoropyrimidine therapy.
    Brody JR; Hucl T; Gallmeier E; Winter JM; Kern SE; Murphy KM
    Cancer Res; 2006 Oct; 66(19):9369-73. PubMed ID: 17018589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomic dissection of resistance to thymidylate synthase inhibitors.
    Wang W; Marsh S; Cassidy J; McLeod HL
    Cancer Res; 2001 Jul; 61(14):5505-10. PubMed ID: 11454699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization and sensitization of cells to fluoropyrimidines with different antisenses directed against thymidylate synthase messenger RNA.
    Ju J; Kane SE; Lenz HJ; Danenberg KD; Chu E; Danenberg PV
    Clin Cancer Res; 1998 Sep; 4(9):2229-36. PubMed ID: 9748143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer.
    Xi Y; Nakajima G; Schmitz JC; Chu E; Ju J
    BMC Genomics; 2006 Apr; 7():68. PubMed ID: 16584549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma.
    Feng H; Cheung AN; Xue WC; Wang Y; Wang X; Fu S; Wang Q; Ngan HY; Tsao SW
    Gynecol Oncol; 2004 Aug; 94(2):375-82. PubMed ID: 15297175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.